The Interventional Effect of Folic Acid on the Development of Gastric and Other Gastrointes-tinal Cancers Clinical Trial and Follow-up for Seven Years

Joel Mason,Robert Russell

DOI: https://doi.org/10.3969/j.issn.1008-7125.2002.02.003

2002-01-01

Abstract:Aims: To evaluate the interventional roles of folic acid and β-carotene in chemoprevention of gastric and other gastrointestinal cancers. Methods: In a randomized, double-blind, placebo-controlled trial, a tot al of 216 patients with atrophic gastritis were assigned to one of the four groups: ① folate(20 mg per day plus vitamin B12 1 mg i.m. per month for one year, then folate 20 mg twice a week plus vitamin B12 1 mg per three months for the next year);② natural β-carotene(N-βC, 30 mg per day in the first year, then 30 mg twi ce a week for the next year); ③ synthetic β-carotene(S-βC, administered as in N-1βC); ④ placebo. All pa tients were followed-up from 1994 to 2001. Results: A total of 5 new cases of gastrointestinal cancers were diagnosed in the placebo group(3 gastric cancer, 1 colonic cancer and 1 esophageal cancer). There was one gastric cancer in each of N-βC group and S-βC group, but none in folate group. Taking gastric cancer as the end point, each of the three interventional groups did not reach statistical significance, but the combined interventional group almost reached(P= 0.06). Taking gastrointestinal cancer as the end point, there was a significant decrease of gastric cancer in folate group as compared with placebo group(P= 0.04), a similar trend was observed in both N-βC group and S-βC group(P=0.07-0.08) and a highly significant decrease was found in the combination of the three interventional groups(P= 0.04). A lower relative risk(odds ratio 0. 12, 95% confidence interval 0.03-0.51) of gastrointestinal cancer was obviously observed. 1. In folate group the gastric mucosal inflammation and the reversed atrophic lesion were stable (P= 0.04), the reverse of intestinal metaplasia approached to 'significant'(P= 0.06). Dysplasia was sig nificantly reversed at 12 months after treatment(P= 0.017). Two cases were found to have yellowish discoloration of skin inβ-carotene groups during follow-up and no side effects were observed in folate group. Conclusions: This study suggests that folate is effective in the intervention of gastro intestinal cancer, and 13-carotene has a similar trend of effectiveness. Folate may be used for atrophic gastritis to revert the gastric precancerous lesions.